So you’ve secured a meeting with a prospect from one of your top-tier pharma, biopharma, or academia target organizations. Excited? For sure. But you still have a lot to do to prepare. Research, Research, and, Hey, Did We Mention Research? The first step in preparing...
As of 2018, more than 3,200 Emerging Biopharma (EBP) companies (characterized by R&D spend of less than $200 million or prescription sales up to $500 million) have an active R&D drug pipeline. Of the 8,700 products or programs in active development, ranging...
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.